Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
about
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience.Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.
P2860
Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Platinum-based doublet chemoth ...... mono-institutional experience.
@ast
Platinum-based doublet chemoth ...... mono-institutional experience.
@en
type
label
Platinum-based doublet chemoth ...... mono-institutional experience.
@ast
Platinum-based doublet chemoth ...... mono-institutional experience.
@en
prefLabel
Platinum-based doublet chemoth ...... mono-institutional experience.
@ast
Platinum-based doublet chemoth ...... mono-institutional experience.
@en
P2093
P50
P1433
P1476
Platinum-based doublet chemoth ...... mono-institutional experience.
@en
P2093
Antonio Jirillo
Cristina Magro
Federico Rea
Laura Bonanno
Paolo Carli
Samuele Nicotra
P304
P356
10.1016/J.LUNGCAN.2011.01.005
P577
2011-02-05T00:00:00Z